Anew Medical
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Anew Medical generated cash of -$1,262,659, which is less than the previous year. Cash used in financing activities reached the amount of -$100,819,861 last year. Net change in cash is therefore -$168,427.
Cash Flow
| 2022 | -493.04K | -116.15M | 116.97M |
|---|---|---|---|
| 2023 | -1.26M | 101.91M | -100.81M |
WENA Cash Flow Statement (2022 – 2023)
| 2023 | 2022 | |
|---|---|---|
Cash at beginning of period | 340.96K | 4.95K |
Operating activities | ||
Net income | 1.34M | 1.23M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||
Depreciation and amortization | 0 | 0 |
Stock-based compensation expense | 0 | 1.4K |
| Deferred income tax benefit | 0 | 1.4K |
| Changes in operating assets and liabilities: | ||
Accounts receivable, net | 0 | 0 |
Inventories | 0 | 0 |
Accounts payable | 0 | -7.12K |
Cash generated by operating activities | -1.26M | -493.04K |
Investing activities | ||
Purchases Of Investments | 0 | -116.15M |
Investments In Property Plant And Equipment | 0 | -125.40K |
Acquisitions Net | 0 | 0 |
Cash generated by investing activities | 101.91M | -116.15M |
Financing activities | ||
Common Stock Issued | 0 | 750K |
Payments for dividends | 0 | 0 |
Repurchases of common stock | 0 | 0 |
Repayments of term debt | 0 | 0 |
Cash used in financing activities | -100.81M | 116.97M |
Net Change In Cash | -168.42K | 336.01K |
Cash at end of period | 172.53K | 340.96K |